Human TCR α/β+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vβ TCR diversity and are clonally related to CD8 + T cells

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 440-448

  Bristeau Leprince, Anne ^a,b   Mateo, Véronique ^c   Lim, Annick ^a,b   Magerus Chatinet, Aude ^c   Solary, Eric ^d   Fischer, Alain ^c   Rieux Laucat, Frédéric ^c   Gougeon, Marie Lise ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; AUTOANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CLINICAL FEATURE; CLONAL VARIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TECHNOLOGY; ADULT; AMINO ACID SEQUENCE; CELL SEPARATION; CHEMISTRY; CHILD; FEMALE; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INFANT; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, CD4; ANTIGENS, CD8; AUTOANTIGENS; AUTOIMMUNE DISEASES; BASE SEQUENCE; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ANALYSIS, PROTEIN; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 47949129249     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.440     Document Type: Article

References (43)

1. Bidere, N., H. C. Su, and M. J. Lenardo. 2006. Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24: 321-352.
2. Rieux-Laucat, F., F. Le Deist, and A. Fischer. 2003. Autoimmune lymphopro-Iiferative syndrome: genetic defects of apoptosis pathways. Celt Death Differ. 10: 124-133.
3. Sneller, M. C., S. E. Strauss, J. S Jaffe, T. A Fleisher, M. Stetler-Stevenson, and W. Strober. 1992. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest. 90: 334-341.
4. Rieux-Laucat, F., F. Le Deist, C. Hivroz, M. C. Sneller, S. E. Straus, E. S. Jaffe, T. A. Jaffe, T. A. Fleisher, M. Stetler-Stevenson, and W. Strober. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349.
5. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
6. Drappa, J., A. K. Vaishnaw, K. E. Sullivan, J. L. Chu, and K. B. Elkon. 1996. Fas gene mutation in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Eng. J. Med. 335: 1643-1649.
7. Bettinardi, A., D. Brugnoni, E. Quiros-Roldan, A. Malagoli, S. La Grutta, A. Correra, and L. D. Notarangelo. 1997. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immu-nological analysis. Blood 89: 902-909.
8. Krammer, P. H. 2000. CD95′s deadly mission in the immune system. Nature 407: 789-795.
9. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 16: 39-43.
10. Rieux-Laucat, F., A. Fischer, and F. Le Deist. 2003. Cell-death signaling and human disease. Curr. Opin. Immunol. 15: 325-331.
11. Jackson, C. E., R. E. Fischer, A. P. Hsu, S. M Anderson, Y. Choi, J. Wang, J. K. Dale, T. A. Fleisher, L. A. Middleton, M. C. Sneller, et al. 1999. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences pen-etrance. Am. J. Hum. Genet. 64: 1002-1014.
12. Rieux-Laucat, F., S. Blachere, S. Danielan, J. P. De Villartay, M. Oleastro, E. Solary, B. Bader-Meunier, P. Arkwright, C. Pondare, F. Bernaudin, et al. 1999. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 94: 2575-2582.
13. Wu, J., J. Wilson, J. He, L. Xiang, P. H. Schur, and J. D. Mountz. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98: 1107-1113.
14. Wang, J., L. Zheng, A. Lobito, F. K. Chan, J. Dale, M. Sneller, X. Yao, J. M. Puck, S. E. Straus, and M. J. Lenardo. 1999. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98: 47-58.
15. Holzelova, E., C. Vonarbourg, M. C. Stolzenberg, P. D. Arkwright, F. Selz, A. M. Prieur, S. Blanche, J. Bartunkova, E. Vilmer, A. Fischer, et al. 2004. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N. Engl. J. Med. 351: 1409-1418.
16. + T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin. Immunol. 100: 314-324.
17. Lopatin, U., X. Yao, R. K. Williams, J. J. Bleesing, J. K Dale, D. Wong, J. Teruya-Feldstein, J. S. Fritz, M. R. Morrow, I. Fuss, et al. 2001. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 97: 3161-3170.
18. - α β T cells of autoimmune lymphoproliferative syndrome. Br. J. Haematol. 119: 535-538.
19. Fuss, I. J., W. Strober, J. K. Dale, S. Fritz, G. R. Pearlstein, J. M. Puck, M. J. Lenardo, and S. E. Straus. 1997. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J. Immunol. 158: 1912-1918.
20. + T cell immune responses. J. Immunol. Methods 261: 177-194.
21. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90: 4319-4323.
22. Pannetier, C., J. Even, and P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16: 176-181.
23. Bousso, P., A. Casrouge, J. D. Altman, M. Haury, J. Kanellopoulos, J. P. Abastado, and P. Kourilsky. 1998. Individual variations in the murinc T cell response to a specific peptide reflect variability in naive repertoires. Immunity 9: 169-178.
24. Mateo, V., M. Menager, G. de Saint-Basile, M. C. Stolzenberg, B. Roquelaure, N. Andre, B. Florkin, F. le Deist, C. Picard, A. Fischer, and F. Rieux-Laucat. 2007. Perforin-dependent apoptosis functionally compensates Fas-deficiency in activation-induced cell-death of human T-lymphocytes. Blood 110: 4285-4292.
25. Rieux-Laucat, F. 2006. Inherited and acquired death receptor defects in human autoimmune lymphoproliferative syndrome. Curr. Dir. Autoimmun. 9: 18-36.
26. Le Deist, F., J. F Emile, F. Rieux-Laucat, M. Benkerrou, I. Roberts, N. Brousse, and A. Fischer. 1996. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 348: 719-723.
27. Sneller, M. C., J. Wang, J. K. Dale, W. Strober, L. A. Middelton, Y. Choi, T. A. Fleisher, M. S. Lim, E. S. Jaffe, J. M. Puck, et al. 1997. Clinical, immu-nologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89: 1341-1348.
28. Morse, H. C., W. F. Davidson, R. A. Yetter, E. D. Murphy, J. B. Roth, and R. L. Coffman. 1982. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J. Immunol. 129: 2612-2615.
29. -), TCR a β-expressing, peripheral T cells. Scand. J. Immunol. 34: 679-688.
30. - double negative regulatory T cells. Blood 105: 2828-2835.
31. + T cells. Autoimmunity 40: 299-301.
32. + cells based on high affinity TCR signals. J. Immunol. 162: 5747-5756.
33. + thymic precursor. J. Immunol. 151: 1086-1091.
34. - thymocytes that express the T cell receptor may have previously expressed CDS. Int. Immunol. 2: 51-56.
35. + cells in lpr/lpr mice lacking b2-microglobulin. J. Immunol. 154: 2063-2067.
36. - α β T cells of autoimmune lymphoproliferative syndrome. Br. J. Haematol. 119: 535-538.
37. Fitzpatrick, L., A. P. Makrigiannis, M. Kaiser, and D. W. Hoskin. 1996. Anti-CD3-activated killer T cells: interferon-7 and interleukin-10 cross-regulate gran-zyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity. J. Interferon Cytokine Res. 16: 537-546.
38. Pestano, G. A., Y. Zhou, L. A. Trimble, J. Daley, G. F Weber, and H. Cantor. 1999. Inactivation of misselected CDS T cells by CD8 gene methylation and cell death. Science 284: 1187-1191.
39. Teachey, D. T., D. A. Obzut, K. Axsom, J. K. Choi, K. C. Goldsmith, J. Hall, J. Hulitt, C. S. Manno, J. M. Maris, N. Rhodin, et al. 2006. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood 108: 1965-1971.
40. Hamad, A. R., A. Srikrishnan, P. Mirmonsef, C. P. Broeren, C. H. June, D. Pardoll, and J. P. Schneck. 2001. Lack of coreceptor allows survival of chronically stimulated double-negative α/β T cells: implications for autoimmunity. J. Exp. Med. 193: 1113-1121.
41. Clambey, E. T., J. W. Kappler, and P. Marrach. CDS T cell clonal expansions and aaing: a heterogeneous phenomenon with a common outcome. Exp. Cerontol. 42: 407-411
42. Ford, M. S., K. J. Young. Z. Zhang, P. S. Ohashi, and L. Zhang. 2002. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J. Exp. Med. 196: 261-267.
43. Watanabe, N., K. Ikuta, S. Nisitani, T. Chiba, and T. Honjo. 2002. Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. J. Exp. Med. 196: 141-146.